Non Hodgkin's Lymphoma News and Research

RSS
The Non-Hodgkin lymphomas (NHLs) are a diverse group of hematologic cancers which encompass any lymphoma other than Hodgkin's Lymphoma.
NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

Scientists identify gene mutation behind Waldenstrom's macroglobulinemia

Scientists identify gene mutation behind Waldenstrom's macroglobulinemia

Re-treatment with rituximab may benefit patients with LTB follicular lymphoma

Re-treatment with rituximab may benefit patients with LTB follicular lymphoma

New findings from Micromet's blinatumomab phase 1 trial on DLBCL

New findings from Micromet's blinatumomab phase 1 trial on DLBCL

Breakthroughs in hematopoietic cell transplantation to be presented at 53rd ASH meeting

Breakthroughs in hematopoietic cell transplantation to be presented at 53rd ASH meeting

People in Northern Ireland less likely to develop cancers

People in Northern Ireland less likely to develop cancers

FDA assigns CTIs' pixantrone NDA new PDUFA action date

FDA assigns CTIs' pixantrone NDA new PDUFA action date

CTI seeks license to market Pixuvri in the E.U. for treatment of NHL

CTI seeks license to market Pixuvri in the E.U. for treatment of NHL

Treatments for lymphoma with no side effects

Treatments for lymphoma with no side effects

ASH recognizes abstract presenters at 53rd annual meeting in San Diego

ASH recognizes abstract presenters at 53rd annual meeting in San Diego

John Theurer Cancer Center to present results of 31 studies at ASH 2011 meeting

John Theurer Cancer Center to present results of 31 studies at ASH 2011 meeting

Study reveals underlying molecular mechanism contributing to development of lymphomagenesis

Study reveals underlying molecular mechanism contributing to development of lymphomagenesis

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

New data from Pfizer's hematology portfolio to be presented at 53rd ASH annual meeting

New data from Pfizer's hematology portfolio to be presented at 53rd ASH annual meeting

Pharmacyclics first quarter GAAP net loss increases to $14.5M

Pharmacyclics first quarter GAAP net loss increases to $14.5M

UCB to sponsor several key sets of Cimzia data on RA at ACR 2011 meeting

UCB to sponsor several key sets of Cimzia data on RA at ACR 2011 meeting

Study: Melanoma survivors more likely to have new cancers

Study: Melanoma survivors more likely to have new cancers

Solid organ transplant may increase risk of cancer

Solid organ transplant may increase risk of cancer

UCB to present new data on Cimzia at ACG annual scientific meeting

UCB to present new data on Cimzia at ACG annual scientific meeting

Diet, body weight in young adulthood associated with risk for NHL

Diet, body weight in young adulthood associated with risk for NHL